Global Research on In Vitro Lung Model Market “Estimated to Reach US$ 427.4 Million by 2023”

RnRMarketResearch added new research on The lung in vitro models market is expected to reach USD 427.4 million by 2023 from an estimated USD 190.5 million in 2018, at a CAGR of 17.5%. Focus on developing alternatives for animal testing models, advancements in 3D cell culture technology, and the development of new 3D in vitro models are factors driving the growth of this market.

Download Free Sample Report at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1488259 .

The human lung is the main portal of entry for aerosolized nanomaterials, therefore the fundamental understanding of the interaction of those particles with lung cells is of great interest In the field of human health, animal testing is still the most prevalent model used for risk assessment, study of diseases and new drug development.

Introduction
1 Market Definition
2 Currency
3 Limitations
4 Assumptions for the Study
5 Years Considered for the Study
6 Segmentation

The major players in the in vitro lung model market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

In Vitro Lung Model Market, By Application
1 Introduction
2 Applications of 2D Models
3 Applications of 3D Models

In Vitro Lung Model Market, By Region
1 Introduction
2 North America
3 Europe
4 APAC
5 RoW

Click Now for More Details on “In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=1488259 .

The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

Target Audience for this report
1 Biotechnology companies that are into tissue engineering and development of 3D in vitro models
2 Pharmaceutical industries
3 Academic and government research institutes
4 Contract research organizations (CROs)
5 Venture capitalists and investors

List of Tables
1 Lung In Vitro Models Market, By Type, 2016–2023 (USD Million)
2 In Vitro Lung Model Market, By Region, 2016–2023 (USD Million)
3 2D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
4 3D Market, By Type, 2016–2023 (USD Million)
5 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
6 Commercialized 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
7 Commercialized 3D In Vitro Lung Model Market, By Region, 2016–2023 (USD Million)
8 In-House 3D Lung In Vitro Models Market, By Application, 2016–2023 (USD Million)
9 In-House 3D Lung In Vitro Models Market, By Region, 2016–2023 (USD Million)
10 2D In Vitro Lung Model Market, By Application, 2016–2023 (USD Million)

Buy Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=1488259 .

Request for call back:
sales@rnrmarketresearch.com / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.